Sanara MedTech Inc. (SMTI) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1200 SUMMIT AVE FORT WORTH, TX 76102 |
| State of Incorp. | TX |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 20,688 | 15,878 | 16,277 | 6,150 | 2,828 | 5,147 | |||
| Cash and cash equivalent | 20,688 | 15,878 | 16,277 | 6,150 | 2,828 | 5,147 | |||
| Receivables | 1,101 | 1,079 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 3,159 | 2,753 | 3,008 | 3,565 | 4,229 | 4,718 | |||
| Inventory | 3,159 | 2,753 | 3,008 | 3,565 | 4,229 | 4,718 | |||
| Other undisclosed current assets | 12,995 | 13,573 | 11,543 | 11,096 | 10,129 | 9,141 | |||
| Total current assets: | 36,843 | 33,306 | 31,908 | 20,811 | 17,187 | 19,006 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,174 | 1,448 | 1,689 | 1,792 | 1,895 | 1,995 | |||
| Property, plant and equipment | 2,056 | 432 | 996 | 1,116 | 1,191 | 1,258 | |||
| Long-term investments and receivables | 10,690 | 8,297 | 8,321 | 3,084 | 3,084 | 3,084 | |||
| Long-term investments | 10,690 | 8,297 | 8,321 | 3,084 | 3,084 | 3,084 | |||
| Intangible assets, net (including goodwill) | 45,616 | 44,609 | 45,631 | 46,579 | 47,555 | 48,528 | |||
| Goodwill | 3,602 | 3,602 | 3,602 | 3,602 | 3,602 | 3,602 | |||
| Intangible assets, net (excluding goodwill) | 42,014 | 41,007 | 42,029 | 42,977 | 43,954 | 44,926 | |||
| Total noncurrent assets: | 59,536 | 54,786 | 56,637 | 52,572 | 53,725 | 54,865 | |||
| TOTAL ASSETS: | 96,379 | 88,092 | 88,545 | 73,384 | 70,912 | 73,871 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 10,914 | 13,401 | 10,542 | 9,191 | 9,182 | 9,724 | |||
| Accrued liabilities | 10,914 | 13,401 | 10,542 | 9,191 | 9,182 | 9,724 | |||
| Debt | 580 | ||||||||
| Other liabilities | 1,907 | 1,086 | 979 | 1,100 | |||||
| Other undisclosed current liabilities | 2,367 | 1,889 | 1,891 | 1,290 | 2,585 | 2,363 | |||
| Total current liabilities: | 13,281 | 15,290 | 14,340 | 11,566 | 12,746 | 13,768 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 43,402 | 30,689 | 30,077 | 14,371 | 8,768 | 9,113 | |||
| Long-term debt, excluding current maturities | 43,402 | 30,689 | 30,077 | 14,371 | 8,768 | 9,113 | |||
| Liabilities, other than long-term debt | 1,859 | 1,985 | 3,413 | 4,167 | 4,404 | 4,460 | |||
| Other liabilities | 771 | 748 | 2,006 | 2,654 | 2,778 | 2,723 | |||
| Operating lease, liability | 1,088 | 1,237 | 1,407 | 1,513 | 1,626 | 1,737 | |||
| Other undisclosed noncurrent liabilities | 1,169 | 1,216 | 1,261 | 1,878 | 1,982 | 1,942 | |||
| Total noncurrent liabilities: | 46,430 | 33,890 | 34,751 | 20,416 | 15,154 | 15,515 | |||
| Total liabilities: | 59,711 | 49,180 | 49,091 | 31,982 | 27,900 | 29,283 | |||
| Equity | |||||||||
| Equity, attributable to parent | 36,671 | 39,404 | 39,784 | 41,706 | 43,291 | 44,832 | |||
| Common stock | 9 | 9 | 9 | 9 | 9 | 9 | |||
| Additional paid in capital | 77,974 | 77,179 | 76,022 | 75,086 | 73,180 | 72,861 | |||
| Accumulated deficit | (41,312) | (37,784) | (36,246) | (33,388) | (29,898) | (28,037) | |||
| Equity, attributable to noncontrolling interest | (3) | (492) | (330) | (304) | (279) | (244) | |||
| Total equity: | 36,668 | 38,912 | 39,454 | 41,402 | 43,012 | 44,588 | |||
| TOTAL LIABILITIES AND EQUITY: | 96,379 | 88,092 | 88,545 | 73,384 | 70,912 | 73,871 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 23,434 | 26,305 | 21,672 | 20,159 | 18,537 | 17,690 | ||
| Cost of revenue | (1,835) | (2,249) | (1,992) | (2,009) | (1,890) | (1,788) | ||
| Gross profit: | 21,599 | 24,056 | 19,680 | 18,150 | 16,647 | 15,902 | ||
| Operating expenses | (23,679) | (24,431) | (21,604) | (21,035) | (18,178) | (16,128) | ||
| Operating loss: | (2,080) | (375) | (1,924) | (2,885) | (1,532) | (226) | ||
| Nonoperating expense (Other Nonoperating expense) | (1,447) | (1,326) | (959) | (644) | (267) | (36) | ||
| Interest and debt expense | (287) | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (3,527) | (1,701) | (2,883) | (3,529) | (1,799) | (550) | ||
| Other undisclosed income from continuing operations before income taxes | 287 | |||||||
| Net loss: | (3,527) | (1,701) | (2,883) | (3,529) | (1,799) | (262) | ||
| Net income attributable to noncontrolling interest | 0 | 162 | 25 | 25 | 35 | 25 | ||
| Net loss available to common stockholders, diluted: | (3,527) | (1,539) | (2,858) | (3,504) | (1,764) | (237) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (3,527) | (1,701) | (2,883) | (3,529) | (1,799) | (262) | ||
| Comprehensive loss: | (3,527) | (1,701) | (2,883) | (3,529) | (1,799) | (262) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 0 | 162 | 25 | 25 | 35 | 25 | ||
| Comprehensive loss, net of tax, attributable to parent: | (3,527) | (1,539) | (2,858) | (3,504) | (1,764) | (237) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.